Click on a link in the list to view Yozma news and related events.
Yozma will reportedly sell 7% of Internet company Conduit to JPMorgan Chase at a company value of $1.3 billion.
Kyphon Signs Definitive Agreements to Acquire All Spine-Related Assets of Disc-O-Tech Medical Technologies
Collaboration Includes Discovery and Development of Four GPCR Programs
Neurosonix has developed a device intended to prevent coronary embolisms from reaching the brain.
EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX - News) announced today the completion of its previously announced merger with Predix Pharmaceuticals Holdings, Inc.
Predix Pharmaceuticals Announces Collaboration for Development of S1P1 Modulators for the Treatment of Autoimmune Diseases
The company’s value has risen 50% since its IPO in October 2005
Jointly announced the signing of a definitive merger agreement whereby EPIX will acquire Predix in a transaction valued at approximately $90 million
Biotech investor Michael Weiss will assist in raising interest among potential investors.
NeuroSonix is developing non-invasive technology for the protecting the brain from embolisms during open-heart surgery
Cystic Fibrosis Foundation Therapeutics and Predix Pharmaceuticals Announce Drug Discovery Collaboration to Treat Cystic Fibrosis
The Israeli-US start-up integrates computational and medicinal chemistry to create new drugs
NextNine Ltd. announced the completion of a $5 million financing round
US Physiome Sciences and Israeli Predix Pharmaceuticals announce merger
The main investors of the merged company are DRKC Life Science Partners, OrbiMed Advisors and Yozma Venture Capital
X-Technologies receives FDA marketing approval
The announcement means Guidant is obliged to pay the remainder of the acquisition price for the company it bought two months ago
Advisors & Partners
News & Events